Table of Contents
Gepants are a class of medications used specifically for the acute treatment and prevention of migraines. They are calcitonin gene-related peptide (CGRP) receptor antagonists that provide an alternative to triptans, especially for patients with contraindications or those who do not respond well to other therapies.
Overview of Gepants
Gepants are designed to block the CGRP pathway, which plays a significant role in migraine pathophysiology. They are taken orally and have a favorable safety profile, making them suitable for many patients.
Approved Gepants and Their Dosing
Ubrogepant (Ubrelvy)
Ubrogepant is approved for the acute treatment of migraine with or without aura in adults. The recommended dose is 50 mg taken orally as needed. If the pain persists or returns, a second dose can be taken after 2 hours, with a maximum of 200 mg per day.
Rimegepant (Nurtec ODT)
Rimegepant is approved for both acute treatment and preventive therapy. For acute treatment, the recommended dose is 75 mg taken orally as needed. It can be repeated after 2 hours if necessary, with a maximum of 75 mg per day for acute use.
Use Guidelines and Considerations
Gepants are generally well-tolerated, but some considerations are important for safe use:
- Timing: Take at the onset of migraine symptoms for best efficacy.
- Frequency: Do not exceed the recommended dose or frequency to avoid adverse effects.
- Contraindications: Avoid in patients with severe hepatic impairment or known hypersensitivity.
- Drug interactions: Be cautious with medications that affect liver enzymes or have similar side effect profiles.
Monitoring and Safety
Patients should be monitored for any adverse reactions, including nausea, dizziness, or allergic responses. Liver function tests may be recommended in long-term use, especially in patients with pre-existing liver conditions.
Summary
Gepants offer a targeted and effective option for migraine management, with flexible dosing and a good safety profile. Proper adherence to dosing guidelines ensures optimal outcomes and minimizes risks.